Abstract | BACKGROUND: OBJECTIVE: To examine the expression of NF-κB signaling pathway components and PKR in CSDH outer membranes. METHODS: Eight patients whose outer membranes were successfully obtained during trepanation surgery were included in this study. The IκBα, IKKβ, IKKγ, NF-κB, phosphorylated ( p )-NF-κB, and PKR expression levels were examined using western blotting analysis. NF-κB expression was also examined using immunohistochemistry. We investigated whether CSDH fluid could activate NF-κB in cultured endothelial cells in Vitro. RESULTS: The IκBα, IKKβ, IKKγ, and NF-κB levels were approximately the same. Additionally, p -NF-κB and PKR were detected at similar levels. Immunostaining showed that NF-κB was expressed in the vascular endothelium. p -NF-κB expression in endothelial cells was significantly induced immediately after treatment with CSDH fluid. Furthermore, NF-κB activation was significantly inhibited by treatment with antibodies directed against vascular endothelial growth factor. CONCLUSION: PKR might activate NF-κB through vascular endothelial growth factor in endothelial cells, which might be associated with endothelial cell proliferation in the CSDH outer membrane. Thus, the NF-κB signaling pathway could play a critical role in CSDH growth.
|
Authors | Koji Osuka, Yasuo Watanabe, Nobuteru Usuda, Masahiro Aoyama, Reo Kawaguchi, Mikinobu Takeuchi, Masakazu Takayasu |
Journal | Neurosurgery
(Neurosurgery)
Vol. 80
Issue 4
Pg. 571-578
(04 01 2017)
ISSN: 1524-4040 [Electronic] United States |
PMID | 28362919
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2016 by the Congress of Neurological Surgeons |
Chemical References |
- NF-kappa B
- Vascular Endothelial Growth Factor A
|
Topics |
- Aged
- Cell Proliferation
- Endothelial Cells
(metabolism)
- Female
- Hematoma, Subdural, Chronic
(metabolism)
- Humans
- Male
- Middle Aged
- NF-kappa B
(metabolism)
- Neovascularization, Pathologic
(metabolism)
- Phosphorylation
- Signal Transduction
(physiology)
- Vascular Endothelial Growth Factor A
(metabolism)
|